X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-second-over-the-counter-opioid-overdose-reversal-drug-2023-07-28/
https://www.prnewswire.com/news-releases/harm-reduction-therapeutics-new-drug-application-for-rivive-over-the-counter-naloxone-nasal-spray-accepted-and-granted-priority-review-by-fda-301710002.html
https://www.prnewswire.com/news-releases/over-the-counter-naloxone-one-step-closer-as-harm-reduction-therapeutics-initiates-a-rolling-submission-of-its-new-drug-application-nda-to-us-food-and-drug-administration-for-rivive-3-0-mg-intranasal-naloxone-for-emergency--301645959.html
https://www.prnewswire.com/news-releases/harm-reduction-therapeutics-signs-commercial-supply-agreement-for-fast-tracked-naloxone-nasal-spray-to-reverse-opioid-overdoses-301603546.html
https://endpts.com/purdue-shells-out-a-little-more-cash-for-a-non-profit-biotech-working-on-naloxone-otc-nasal-spray/
Market Place
Share 
